Clinical Trials Browser

Phase 1/2 × Alzheimer Disease × Clear all

NCT04971733 2025-06-10

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Phase 1/2 Completed

8 enrolled 21 charts

Alzheimer Disease, Central Nervous System Diseases, Lymphoma, Follicular

NCT03236792 2022-09-29

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Phase 1/2 Completed

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease

NCT02072252 2017-08-17

TODAY!

Phase 1/2 Withdrawn

Generalized Anxiety Disorder, Alzheimer Disease, Anxiety Disorders, Bisexuality, Depression, Homosexuality, Multiple Endocrine Neoplasia Type 1